A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1997
11/19/1997	CN1165521A Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
11/19/1997	CN1165480A Liposome-formulation for treatment of viral diseases
11/19/1997	CN1165471A Antiparasitic composition for treating and protecting pets
11/19/1997	CN1165035A Antigen-antibody-recombination DNA composite type vaccin
11/19/1997	CN1165028A Powerful disinfactant
11/18/1997	US5689048 Biocidal proteins
11/18/1997	US5688965 Bactericides
11/18/1997	US5688942 Process for preparing 2-isocephem derivatives
11/18/1997	US5688924 Derivatives of 12,13-Epoxy-tylosin and processes of manufacture thereof
11/18/1997	US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen
11/18/1997	US5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent
11/18/1997	US5688771 Lipophilic oligopeptides with immunomodulating activity
11/18/1997	US5688688 Vector for expression of a polypeptide in a mammalian cell
11/18/1997	US5688659 Incubation of sample peptide antigen to form antigen-antibody complex detection of antibodies
11/18/1997	US5688637 Kits for detection of aids, amplification of strands of nucleic acid and hybridization in the presence of polymerases
11/18/1997	US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents
11/18/1997	US5688522 Ointment for wound treatment
11/18/1997	US5688512 Vaccines
11/18/1997	US5688501 Treating infectious disease caused by bacteria by administering bacteriophages obtained by serial passage through circulatory system and selected to have longer half-life
11/13/1997	WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997	WO1997042204A1 6-o-substituted erythromycins and method for making them
11/13/1997	WO1997042195A1 Process for the preparation of an indacene compound
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997042156A1 Anti-viral compounds
11/13/1997	WO1997042155A1 Anti-viral compounds
11/13/1997	WO1997042154A1 Anti-viral compounds
11/13/1997	WO1997041889A1 Feline vaccines containing chlamydia psittaci and method for making the same
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041884A1 Method of treatment
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041861A1 Anti-viral compounds
11/13/1997	WO1997041860A1 Anti-viral compounds
11/13/1997	WO1997041855A1 Method for treating viral infections
11/13/1997	WO1997041853A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997	WO1997041849A1 Anti-viral method
11/13/1997	WO1997041847A1 Antioxidant compounds
11/13/1997	WO1997041846A1 Anti-viral compounds
11/13/1997	WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997	WO1997041822A2 Anti-viral compounds
11/13/1997	WO1997033996A3 Human bikunin
11/13/1997	WO1997032607A3 Activated linkers and methods for making and purifying the same
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253860A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997	CA2253857A1 Anti-viral compounds
11/13/1997	CA2253743A1 Anti-viral method
11/13/1997	CA2253742A1 Anti-viral compounds
11/13/1997	CA2253739A1 Anti-viral compounds
11/13/1997	CA2253502A1 Anti-viral compounds
11/13/1997	CA2253405A1 Anti-viral compounds
11/13/1997	CA2253401A1 Anti-viral compounds
11/13/1997	CA2253398A1 Anti-viral compounds
11/13/1997	CA2253322A1 Gene expression in monocytes and macrophages
11/12/1997	EP0806484A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
11/12/1997	EP0806426A1 Process for the preparation of clavulanic acid
11/12/1997	EP0806418A2 Novel pyrimidine compound and anti-rotavirus agent
11/12/1997	EP0806411A2 Anti-viral compounds
11/12/1997	EP0806410A2 Anti-viral compounds
11/12/1997	EP0806409A1 Anti-viral compounds
11/12/1997	EP0806408A1 Anti-viral compounds
11/12/1997	EP0806205A2 Urea, thiourea and guanidine compounds and their use as anti-viral agents
11/12/1997	EP0806203A2 Anti-viral compositions
11/12/1997	EP0805862A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
11/12/1997	EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997	EP0805854A1 Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/12/1997	EP0805815A1 Bismuth compounds
11/12/1997	EP0805795A1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
11/12/1997	EP0805790A1 Improved synthesis of cyclopropylacetylene
11/12/1997	EP0805691A2 Immunogenic conjugate molecules
11/12/1997	EP0805685A1 Novel antifungal cyclohexapeptides
11/12/1997	EP0805683A1 5-carboxamido or 5-fluoro]- 2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	EP0600026B1 Cardiac output probe assembly
11/12/1997	CN1164855A Antiviral nucleoside analogues containing substituted benzimidazole base attached to carbocyclic ring
11/12/1997	CN1164531A Novel derivatives of 3-bromo-and 3,3-dibromo-4-oxo-1-azetidines, processes for preparation thereof and their use
11/12/1997	CN1164415A Quick specific medicine for treatment of tuberculosis
11/12/1997	CN1036398C Therapeutic nucleosides
11/11/1997	US5686582 Multimeric forms of human rhinovirus receptor protein
11/11/1997	US5686486 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997	US5686441 Penam sulfones as β-lactamase inhibitors
11/11/1997	US5686434 3-aryl-2-isoxazolines as antiinflammatory agents
11/11/1997	US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997	US5686287 Marek's disease virus vaccine
11/11/1997	US5686076 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission
11/11/1997	US5686075 Synthetic peptide vaccines for dental caries
11/06/1997	WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	WO1997041252A2 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997	WO1997041232A1 Antagonists of interleukin-15
11/06/1997	WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	WO1997041201A1 Anol esters as bleach activators for detergents and cleaners
11/06/1997	WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041146A1 Novel compounds
11/06/1997	WO1997041123A1 1-methylcarbapenem derivatives
11/06/1997	WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components

1 ... 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 ... 1798